DiaMedica Therapeutics (DMAC) Current Leases (2018 - 2026)
DiaMedica Therapeutics (DMAC) reported Current Leases of $11000.0 for Q1 2026, down 8.33% on a YoY basis from $12000.0 in Q1 2025, and down 89.11% quarter-over-quarter from $101000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Current Leases (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Current Leases for 9 years, with the latest figure at $11000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 8.33% year-over-year to $11000.0; the trailing twelve-month figure through Mar 2026 stood at $11000.0 (down 8.33% YoY), and the FY2025 full-year result was $101000.0, up 12.22% from the prior year.
- Current Leases for Q1 2026 stood at $11000.0, down from $101000.0 in the prior quarter.
- The five-year high for Current Leases was $101000.0 in Q4 2025, with the low at $3000.0 in Q2 2023.
- Historically, Current Leases has averaged $30352.9 across 5 years, with a median of $12000.0 in 2025.
- Annual changes were most pronounced in 2024 — Current Leases soared 2900.0% — and 2025, when it tumbled 85.54%.
- DiaMedica Therapeutics' Current Leases stood at $6000.0 in 2022, then slumped by 50.0% to $3000.0 in 2023, then soared by 2900.0% to $90000.0 in 2024, then increased by 12.22% to $101000.0 in 2025, then sank by 89.11% to $11000.0 in 2026.
- The last three Current Leases figures came in at $11000.0 (Q1 2026), $101000.0 (Q4 2025), and $10000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | 11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Mar 31, 2024 | 83,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 78,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 34,000.00 |
| Jun 30, 2022 | 11,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 5,000.00 |